Pre-discharge risk stratification in unselected STEMI: Is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 2182-2188

  Dhillon, Onkar S ^a   Narayan, Hafid K ^b   Khan, Sohail Q ^b   Kelly, Dominic ^b   Quinn, Paulene A ^b   Squire, Iain B ^b   Davies, Joan E ^b   Ng, Leong L ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

GRACE score; IL 33; Myocardial Infarction; N terminal B type natriuretic peptide; prognosis; ST2

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 33; MEMBRANE RECEPTOR; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HEART REINFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

GRACE SCORE; IL-33; MYOCARDIAL INFARCTION; N-TERMINAL B TYPE NATRIURETIC PEPTIDE; PROGNOSIS; ST2;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; RECEPTORS, CELL SURFACE; RISK ASSESSMENT;

EID: 84883264973     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.073     Document Type: Article

References (21)

1. S. Sanada, D. Hakuno, and L.J. Higgins IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
2. J. Schmitz, A. Owyang, and E. Oldham IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
3. A.M. Miller, D. Xu, and D.L. Asquith IL-33 reduces the development of atherosclerosis J Exp Med 205 2008 339 346
4. M.S. Sabatine, D.A. Morrow, and L.J. Higgins Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation 117 2008 1936 1944
5. M. Shimpo, D.A. Morrow, and E.O. Weinberg Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2004 2186 2190
6. K.A. Eagle, M.J. Lim, and O.H. Dabbous A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post discharge death in an international registry JAMA 291 2004 2727 2733
7. C.B. Granger, R.J. Goldberg, and O. Dabbous Global Registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353
8. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
9. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
10. J.S. Alpert, K. Thygesen, and E. Antman Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
11. T.D. Smilde, D.J. van Veldhuisen, and G. Navis Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 114 2006 1572 1580
12. O.S. Dhillon, H. Narayan, P.A. Quinn, I.B. Squire, J.E. Davies, and L.L. Ng IL-33 and ST2 levels in NSTEMI: comparsion with GRACE score and NT-proBNP Am Heart J 161 2011 1163 1170
13. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
14. A.S. Leon, B.A. Franklin, and F. Costa Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology and the Council on Nutrition, Physical Activity, and Metabolism, in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation Circulation 111 2005 369 376
15. C.P. Gale, S.O. Manda, C.F. Weston, J.S. Birkhead, P.D. Batin, and A.S. Hall Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database Heart 95 2009 221 227
16. E. Morita, H. Yasue, and M. Yoshimura Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 1993 82 91
17. E.O. Weinberg, M. Shimpo, and G.W. De Keulenaer Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2002 2961 2966
18. M.J. de Boer, H. Suryapranata, and J.C. Hoorntje Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction Circulation 90 1994 753 761
19. M. Grabowski, K.J. Filipiak, and L.A. Malek Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty Int J Cardiol 115 2007 386 390
20. H. Iwahana, K. Yanagisawa, and A. Ito-Kosaka Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12cells Eur J Biochem 264 1999 397 406
21. W.S. Colucci, U. Elkayam, and D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 2000 246 253